Note that some links may require registration or subscription. The Republican party is starting to embrace psychedelics as ...

U.S. Senator Maggie Hassan (D-NH) is intensifying her scrutiny of GSK Plc (NYSE:GSK) over the company's decision to pull its widely used asthma inhaler, Flovent HFA, from the market. One year ...

Flovent HFA had long been the most prescribed controller inhaler for young children with asthma. After it was removed from the market in January 2024, GSK partnered with Prasco Laboratories to ...

Results A total of 508 patients entered the run-in period, of whom 328 were randomised to treatment, 177 to fluticasone propionate 50µg twice daily, and 151 to fluticasone propionate 100µg once ...

BACKGROUND The objective of this multicentre, randomised, double blind, parallel group study was to compare the efficacy and safety of the addition of salmeterol with that of doubling the dose of ...

Abstract and Introduction Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma ...

Sen. Maggie Hassan (D-N.H.) is launching an investigation into GSK's decision to pull its asthma treatment fluticasone propionate (Flovent HFA) from the market. (Reuters via MSN) ...

Fluticasone and Vilanterol (Breo) Leukotriene modifiers reduce swelling and help keep your airways open for up to 24 hours. According to Mayo Clinic, these medications block the effects of ...